SCHEMBL2024877

SCHEMBL2024877

COc1ccc(O)c2cc(C)c(C)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 3/20 0.47
NQO1 P15559 1/20 0.47
MAOB P27338 1/20 0.47
HIF1A Q16665 1/20 0.46
EPAS1 Q99814 1/20 0.46
CSNK2A2 P19784 1/20 0.43
CSNK2B P67870 1/20 0.43
CSNK2A1 P68400 1/20 0.43
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42
TUBB4B P68371 1/20 0.42
TUBB3 Q13509 1/20 0.42
TUBB2A Q13885 1/20 0.42
TUBB8 Q3ZCM7 1/20 0.42
TUBA3E Q6PEY2 1/20 0.42
TUBA1A Q71U36 1/20 0.42
TUBA1C Q9BQE3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8956076 0.88 TUBB1 (0.45) TUBB1NQO1MAOBHIF1AEPAS1
SCHEMBL9097639 0.87 NQO1 (0.58) TUBB1NQO1RAB9AALDH1A1ACHE
SCHEMBL11077415 0.80 NQO1 (0.77) NQO1MAOBHIF1AEPAS1MEN1
SCHEMBL2019633 0.80 ACHE (0.52) MAOBHIF1AEPAS1CSNK2A2CSNK2B
SCHEMBL2024366 0.80 ACHE (0.52) NQO1MAOBHIF1AEPAS1CSNK2A2
SCHEMBL2026448 0.77 PDE4A (0.54) TUBB1MEN1KMT2AALDH1A1TSHR
SCHEMBL9657666 0.75 EP300 (0.43) TUBB1MAOBTUBB4ATUBBTUBA3C
SCHEMBL6839250 0.74 TUBB1 (0.47) TUBB1MAOBHIF1AEPAS1TUBB4A
SCHEMBL217255 0.74 IDO1 (0.59) NQO1HIF1AEPAS1MEN1KMT2A
SCHEMBL3179355 0.74 NQO1 (0.67) NQO1MEN1KMT2AALDH1A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073151-A2 METHOD FOR THE TWO-STEP DYEING OF KERATIN FIBRES, BY APPLICATION OF A COMPOSITION COMPRISING A NAPHTALENE DERIVATIVE, THEN ALKALINE TREATMENT. L'OREAL (FR) 2011-06-23 WO claimed
EP-0850635-B1 Process for oxydative dyeing of keratinic fibers in two steps with a manganese salt or a manganese complex and a 1-naphtol substituted in position 4 and a dyeing set OREAL (FR) 1999-07-14 EP claimed
EP-0850635-A1 Process for oxydative dyeing of keratinic fibers in two steps with a manganese salt or a manganese complex and a 1-naphtol substituted in position 4 and a dyeing set L'OREAL (FR) 1998-07-01 EP claimed
US-20160115106-A1 Stabilization of Chlorinated Olefins AXIALL OHIO, INC. 2016-04-28 US disclosed
WO-2011073151-A2 METHOD FOR THE TWO-STEP DYEING OF KERATIN FIBRES, BY APPLICATION OF A COMPOSITION COMPRISING A NAPHTALENE DERIVATIVE, THEN ALKALINE TREATMENT. L'OREAL (FR) 2011-06-23 WO disclosed
EP-1555993-B1 PERMANENT COLORING OF HAIR USING AN OXIDATION HAIR DYE PRECURSOR AND A METAL CYANATE UNILEVER PLC (GB) 2010-03-24 EP disclosed
EP-1555993-A2 PERMANENT COLORING OF HAIR USING AN OXIDATION HAIR DYE PRECURSOR AND A METAL CYANATE UNILEVER PLC (GB) 2005-07-27 EP disclosed
US-6821302-B2 Oxidation color dye comprising a metal cyanate, free of ammonia, without the pungent odor of ammonia UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2004-11-23 US disclosed
WO-2004039341-A2 PERMANENT COLORING OF HAIR USING AN OXIDATION HAIR DYE PRECURSOR AND A METAL CYANATE UNILEVER PLC (GB) 2004-05-13 WO disclosed
US-20040083557-A1 Permanent coloring of hair using carbonate salts and bicarbonate salts and using percarbamic acid precursors UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2004-05-06 US disclosed
US-20040019980-A1 One step hair coloring compositions using salts UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2004-02-05 US disclosed
EP-0850635-B1 Process for oxydative dyeing of keratinic fibers in two steps with a manganese salt or a manganese complex and a 1-naphtol substituted in position 4 and a dyeing set OREAL (FR) 1999-07-14 EP disclosed
US-5873910-A IN FIRST STAGE APPLYING TO KERATIN FIBER A FIRST SOLUTION CONTAINING IN A DYEING MEDIUM A MANGANESE SALT AND/OR COMPLEX, IN SECOND STAGE, APPLYING TO THE HAIR A SOLUTION WHICH CONTAINS 4-SUBSTITUED NAPHTHOL/1-/ AND AN OXIDIZER L'OREAL (FR) 1999-02-23 US disclosed
EP-0850635-A1 Process for oxydative dyeing of keratinic fibers in two steps with a manganese salt or a manganese complex and a 1-naphtol substituted in position 4 and a dyeing set L'OREAL (FR) 1998-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160115106-A1 Stabilization of Chlorinated Olefins CYCS, CLIC1, CBR3 TUBB1 276/4885NQO1 2820/4885MAOB 2189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.